August 13, 2024

AHIP To Go On Offensive On Medicare Advantage

With Medicare Advantage (MA) facing huge financial difficulties due to lower rates and crippling government regulatory changes, AHIP, the health plan lobby, is underwriting a seven-figure lobbying and advertising campaign to call attention to the challenges, obtain higher rates, and explain the major benefits for Medicare enrollees.

Additional article: https://subscriber.politicopro.com/article/2024/08/top-health-insurance-group-outlines-plans-to-protect-medicare-advantage-00173713

(Some articles may require a subscription.)

#medicareadvantage

https://www.beckerspayer.com/payer/payers-plan-medicare-advantage-lobbying-blitz.html

Kaiser Reports Good Financial Results

Kaiser Permanente wrapped reported $908 million of operating income (3.1% operating margin) and more than $2.1 billion of net income in Q2 2024. It had $29.1 billion in revenue in the quarter. The numbers were up from a year ago. It had a good 1H 2024 and is overcoming its earlier troubles.

Additional article: https://www.fiercehealthcare.com/providers/kaiser-permanente-posts-31-operating-margin-21b-net-income-q2-2024

#kaiserpermanente

https://www.healthcaredive.com/news/kaiser-second-quarter-financial-results-operating-margin-geisinger-risant/724065

Mark Cuban Tells Daily Show He Wants To Shake Up Healthcare

Mark Cuban appeared on The Daily Show to declare that he wants to shake up healthcare. On the show, he told John Stewart the following:

  • He is dedicated to transparency and public contracts.
  • He thinks pharmacy benefits managers are the issue.

#cuban #drugpricing #healthcare

https://www.modernhealthcare.com/insurance/mark-cuban-daily-show-interview-cost-plus-drugs

Sanders Calls For Caps On Inhalers

Senate HELP Chairman Bernie Sanders (I-VT) called on GlaxoSmithKline and Prasco Laboratories to cap the price of the authorized generic version of Flovent, an inhaler covering many children, at $35.

(Article may require a subscription.)

#drugpricing #sanders #branddrugmakers

https://insidehealthpolicy.com/daily-news/sanders-calls-gsk-prasco-labs-cap-inhaler-price-children-35

Think Tank Has Model Legislation On Consolidation

Kudos to the National Academy for State Health Policy (NASHP), which has done stellar work over the years encouraging reform of healthcare at the state level. The latest endeavor is a model bill that would empower state attorneys general and health officials to impose conditions on or veto consolidation transactions. Notwithstanding positive momentum at the federal level, this is important.

(Article may require a subscription.)

#antitrust #consolidation #mergers #acquisitions

https://insidehealthpolicy.com/daily-news/state-policy-experts-offer-model-health-care-consolidation-bill

Majority Of Weight-Loss Drugs Tied To Commercial Insurance

A new study in JAMA Forum finds that more than 61% of Ozempic prescriptions in 2023 went to those with commercial health insurance and less than 10% of all such semaglutide drugs went to Medicaid enrollees. The findings are not unexpected as commercial plans offer more liberal coverage of expensive weight-loss drugs. Medicare and Medicaid tend to restrict coverage to those with certain disease states.

#weightlossdrugs #drugpricing

https://www.beckerspayer.com/payer/majority-of-weight-loss-drug-prescriptions-going-to-commercially-insured-patients.html

— Marc S. Ryan

Leave a Reply

Your email address will not be published. Required fields are marked *

Available Now

$30.00